We report a life-threatening varicella pneumonia in a young man treated with azathioprine and infliximab for Crohn's disease. On timeline he reported a 3-day history of fever, headache, and a progressive, exuberant, cutaneous vesicular rash. He had had contact with a child with varicella, was a smoker, and had no past history of varicella. Anti-varicella Ig G was negative. Work-up was relevant for hypoxaemia [pO 2 = 66 mmHg] while breathing room air, thrombocytopenia [64 000/µl], elevated lactate dehydrogenase [716 UI/l], and C-reactive protein of 44.5 mg/l. Chest radiographs showed diffuse bilateral alveolar infiltrates. A severe adult respiratory distress syndrome developed and he required inotropic support and mechanical invasive ventilation for 11 days. After intravenous acyclovir and aggressive supportive management, the patient was discharged [Day 17] without remarkable sequelae. Infliximab was re-started 2 months after varicella and he is doing well 4 months thereafter. Varicella tends to be severe in adults, and those on corticosteroids and/or on combination of immunosuppressors seem to be at higher risk.
We report a life-threatening varicella pneumonia in a young man treated with azathioprine and infliximab for Crohn's disease. On timeline he reported a 3-day history of fever, headache, and a progressive, exuberant, cutaneous vesicular rash. He had had contact with a child with varicella, was a smoker, and had no past history of varicella. Anti-varicella Ig G was negative. Work-up was relevant for hypoxaemia [pO 2 4 If VZIG is not available, intravenous immunoglobulin [IVIG] may be used, as it has been shown to have high levels of varicella-specific IgG. Prophylaxis with valacyclovir [1 g orally three times daily] is advised by some experts for 3-22 days, if VZIG is not available. 5 If varicella shows up, prompt admission for intravenous acyclovir is mandatory. Most situations of primary VZV infection favour the withdrawal of immunosuppression, as we did. In conclusion, this case highlights the risk of severe VZV primary infection in a doubly immunosuppressed patient and the need for early recognition and aggressive management. 
